E3A Healthcare Triumphs in HKTech300 Competition, Secures a Million Investment from City University of Hong Kong
E3A Healthcare has succeeded in City University of Hong Kong's HKTech300 Start-up Competition, winning a million investment. This victory not only highlights the outstanding innovation ability of E3A Healthcare in the field of newborn and women’s medical devices but also provides solid capital support for the company's future development.
HKTech300 Start-up Competition: An Event for Innovation and Collaboration
On June 27, 2024, the City University of Hong Kong (CityU) hosted the awards ceremony for the HKTech300 Start-up Competition. Ten start-ups from five countries and regions were selected from hundreds of teams, each receiving an HK$1 million angel fund investment from the City University of Hong Kong.
The Award Presentation Ceremony was hosted by Prof. Sun Dong, Secretary for Innovation, Technology and Industry Bureau of the Hong Kong SAR Government, Mr. Lawrence Huang, Chairman of the Council of the City University of Hong Kong (CityU), and Prof. Freddy Boey, President of the City University of Hong Kong (CityU). Mr. Chen Yulin, Director General of the Education Department of the Liaison Office of the Central People's Government in the Hong Kong SAR, and Mr. Vicky Koh, Consul General of the Consulate-General of the Republic of Singapore in Hong Kong, were among the distinguished guests in attendance.
In his speech, Prof. Sun Dong highlighted Hong Kong's reputation as a hub for global start-ups, citing the city's supportive ecosystem and business environment. He emphasized the importance of collaboration between the government, industry, academia, and research sectors in fostering innovation and technology.
Looking Ahead
As a winner of the competition, E3A Healthcare will continue to promote technological innovation and market expansion with the support of the City University of Hong Kong. The company has already established an R&D center and office in Hong Kong Science and Technology Park and is poised for comprehensive expansion in the Hong Kong market, including clinical, R&D, and market growth. E3A Healthcare will leverage Hong Kong's geographical and strategic advantages to further enhance the company's overall development.
E3A Healthcare would like to express its sincerest gratitude to the HKTech300 Competition for providing the platform and support, as well as to the City University of Hong Kong and other partners for their trust and recognition. In the future, E3A Healthcare will continue to uphold the spirit of innovation and excellence and strive to become a global leader in the field of medical devices for women, newborns, and families.